CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment

Article

Abstract: The variability in the antipsychotic response is, to some extent, genetically determined. Several st

Palabras claves:

CYP2D6, EFFECTIVENESS, MDR1, pharmacogenetics, Risperidone, Schizophrenia

Autores:

Abad-Santos F., Adrián LLerena, Almoguera B., Ayuso C., Baca-García E., Dal-Ré R., Dorado P., Fernandez-Piqueras J., Lopez-Castroman J., Riveiro-Alvarez R., Vaquero-Lorenzo C.

Fuentes:

scopus